Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-institutional, Open-label, Single Arm Study of Apatinib in Non-triple-negative Metastatic Breast Cancer

NCT01653561 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT01653561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01653561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-institutional, Open-label, Single Arm Study of Apatinib in Non-triple-negative Metastatic Breast Cancer
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2011
Completion date
October 31, 2012
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms